PLX

Protalix BioTherapeutics, Inc.

Biological Products, (No Diagnostic Substances)NYSENon-accelerated filer<br>Smaller reporting company

Total Trades

5

Buys

4

Sells

1

Largest Trade

$100K–$500K

Insiders

3

Institutional Funds

63

Inst. Value

$1M+

Activist Filings

8

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Bashan DrorPRESIDENT AND CEOBUY$100K–$500K56K$1.81Dec 23, 2025
Bar-Shalev AmosDirectorSELL<$1K168$1.87Nov 19, 2025
Bashan DrorPRESIDENT AND CEOBUY$50K–$100K65K$1.40Oct 20, 2023
Schwartz AharonDirectorBUY$100K–$500K110K$1.42Jan 5, 2023
Bashan DrorPresident and CEOBUY$100K–$500K68K$1.50Apr 13, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 63 funds holding

FundShares
RENAISSANCE TECHNOLOGIES LLC1.3M
GEODE CAPITAL MANAGEMENT, LLC753K
STATE STREET CORP585K
Stratos Wealth Partners, LTD.500K
VANGUARD GROUP INC425K
JANE STREET GROUP, LLC290K
Connor, Clark & Lunn Investment Management Ltd.232K
Main Street Financial Solutions, LLC214K
CHARLES SCHWAB INVESTMENT MANAGEMENT INC175K
COMMONWEALTH EQUITY SERVICES, LLC172K
EVERGREEN CAPITAL MANAGEMENT LLC171K
Round Rock Advisors LLC155K
Diametric Capital, LP139K
GOLDMAN SACHS GROUP INC137K
Bank of New York Mellon Corp114K
BARCLAYS PLC113K
Nuveen, LLC90K
LAZARD ASSET MANAGEMENT LLC71K
HRT FINANCIAL LP65K
Orin Green Financial, LLC61K

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

MAK Capital Fund LP

SC 13G · Mar 4, 2026

5.8%

4.6M shares

Whitebox Advisors LLC

SC 13G/A · Oct 25, 2024

0.0%

0 shares

SC 13G/A · Jan 2, 2024

2.9%

2.2M shares

SC 13G/A · Jan 3, 2023

5.3%

2.8M shares

Whitebox Advisors LLC

SC 13G · Jun 9, 2022

5.7%

2.8M shares

Highbridge Capital Management, LLC

SC 13G/A · Feb 14, 2022

5.0%

2.4M shares

Highbridge Capital Management, LLC

SC 13G/A · Feb 11, 2022

0.0%

0 shares

SC 13G/A · Jan 31, 2022

5.8%

2.8M shares

View on Google Finance →